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1700 J.T. Giacino et alAbstract
Objective: To update the 1995 American Academy of Neurology (AAN) practice parameter on persistent vegetative state and the 2002 case
definition on minimally conscious state (MCS) and provide care recommendations for patients with prolonged disorders of consciousness (DoC).
Methods: Recommendations were based on systematic review evidence, related evidence, care principles, and inferences using a modified Delphi
consensus process according to the AAN 2011 process manual, as amended.
Recommendations: Clinicians should identify and treat confounding conditions, optimize arousal, and perform serial standardized assessments
to improve diagnostic accuracy in adults and children with prolonged DoC (Level B). Clinicians should counsel families that for adults, MCS (vs
vegetative state [VS]/ unresponsive wakefulness syndrome [UWS]) and traumatic (vs nontraumatic) etiology are associated with more favorable
outcomes (Level B). When prognosis is poor, long-term care must be discussed (Level A), acknowledging that prognosis is not universally poor
(Level B). Structural MRI, SPECT, and the Coma Recovery ScaleeRevised can assist prognostication in adults (Level B); no tests are shown to
improve prognostic accuracy in children. Pain always should be assessed and treated (Level B) and evidence supporting treatment approaches
discussed (Level B). Clinicians should prescribe amantadine (100e200 mg bid) for adults with traumatic VS/UWS or MCS (4e16 weeks post
injury) to hasten functional recovery and reduce disability early in recovery (Level B). Family counseling concerning children should
acknowledge that natural history of recovery, prognosis, and treatment are not established (Level B). Recent evidence indicates that the term
chronic VS/UWS should replace permanent VS, with duration specified (Level B). Additional recommendations are included.
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Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation MedicineThis article presents practice guideline recommendations developed
by the American Academy of Neurology (AAN), the American
Congress of Rehabilitation Medicine (ACRM), and the National
Institute on Disability, Independent Living, and Rehabilitation
Research (see complete guideline at http://www.archives-pmr.org/).
A companion article summarizes systematic review conclusions.1
Recommendations
Unless noted, recommendations apply to individuals with pro-
longed disorders of consciousness (DoC) (i.e., 28 days).
Recommendation rationales are presented; tables summarize
recommendations for adults (tables 1e3) and children (table 4).
Recommendation 1 rationale
Our systematic review highlights the complexities of caring for
patients with prolonged DoC (i.e., 28 days) at every stage. Such
patients may be misdiagnosed due to confounding neurologic def-
icits2 or inexperience in examining patients for subtle signs of
consciousness.3 Accurate diagnosis is important to educate families
about patients’ level of consciousness and function, inform prog-
nostic counseling, and guide treatment decisions. Knowledge gaps
often lead to overestimation or underestimation of prognosis by
nonspecialists.4 In addition, patients with prolonged DoC frequently
experience significant medical complications that can slow recovery
and interfere with treatment interventions.5 In view of this risk,
patients are likely to have a better chance for recovery if care isList of abbreviations:
AAN American Academy of Neurology
ACRM American Congress of Rehabilitation Medicine
CI confidence interval
CRS-R Coma Recovery ScaleeRevised
DoC disorders of consciousness
DRS Disability Rating Scale
FDG fluorodeoxyglucose
MCS minimally conscious state
TBI traumatic brain injury
UWS unresponsive wakefulness syndrome
VS vegetative stateprovided in a specialized setting managed by clinicians who are
knowledgeable about the risks associated with DoC and are capable
of initiating timely treatment. This is supported by findings from a
large retrospective trauma registry, which found that cumulative
mortality at 3 years postdischarge is significantly lower for patients
discharged to home or inpatient rehabilitation facilities than those
discharged to skilled nursing facilities, even after adjusting for
covariates.6 Care for patients with prolonged DoC may benefit from
a team of multidisciplinary rehabilitation specialists, including
neurologists, psychologists, neuropsychologists, physiatrists, phys-
ical therapists, occupational therapists, speech pathologists, nurses,
nutritionists, internists, and social workers (supplemental data,
available online only at http://www.archives-pmr.org/).Recommendation 2 rationale
The range of physical and cognitive impairments experienced by
individuals with severe DoC complicates diagnostic accuracy and
makes it difficult to distinguish behaviors that are indicative of
conscious awareness from those that are random and non-
purposeful. Interpretation of inconsistent behaviors or simple motor
responses is particularly challenging. Fluctuations in arousal and
response to command further confound the reliability of clinical
assessment.7,8 Underlying central and peripheral impairments, such
as aphasia, neuromuscular abnormalities, and sensory deficits, may
also mask conscious awareness.9e11 Clinician reliance on non-
standardized procedures, even when the examination is performed
by experienced clinicians,2,12,13 contributes to diagnostic error,
which consistently hovers around 40%. Diagnostic error includes
misdiagnosing the locked-in syndrome for vegetative state/
unresponsive wakefulness syndrome (VS/UWS) and minimally
conscious state (MCS).14,15 Accurate diagnosis of the level of
consciousness has implications for prognosis and management.
Recommendation 2a rationale
In view of the range of clinical challenges to accurate and reliable
diagnosis of DoC, standardizing the assessment of patients with
DoC can assist in recognizing key diagnostic features that may be
missed on ad hoc examinations.12,16 The validity and reliability of
standardized neurobehavioral assessment scales for diagnosis of
DoC subtype have been previously reviewed.17 Other techniqueswww.archives-pmr.org
Table 1 Recommendation statementsa for overall care and diagnosis for adults with a prolonged disorder of consciousness (DoC)
Recommendation Number Recommendation Statement and Level
1 Clinicians should refer patients with DoC who have achieved medical stability to settings staffed by
multidisciplinary rehabilitation teams with specialized training to optimize diagnostic evaluation,
prognostication, and subsequent management, including effective medical monitoring and rehabilitative care
(Level B).
2a Clinicians should use standardized neurobehavioral assessment measures that have been shown to be valid and
reliable (such as those recommended by the ACRM) to improve diagnostic accuracy for the purpose intended
(Level B based on importance of outcomes and feasibility).
2b To reduce diagnostic error in individuals with prolonged DoC after brain injury, serial standardized
neurobehavioral assessments should be performed with the interval of reassessment determined by individual
clinical circumstances (Level B based on cogency, feasibility, and cost relative to benefit).
2c Clinicians should attempt to increase arousal before performing evaluations to assess level of consciousness
anytime diminished arousal is observed or suspected (Level B based on importance of outcomes).
2d Clinicians should identify and treat conditions that may confound accurate diagnosis of a DoC prior to
establishing a final diagnosis (Level B based on feasibility and cost).
2e In situations where there is continued ambiguity regarding evidence of conscious awareness despite serial
neurobehavioral assessments, or where confounders to a valid clinical diagnostic assessment are identified,
clinicians may use multimodal evaluations incorporating specialized functional imaging or electrophysiologic
studies to assess for evidence of awareness not identified on neurobehavioral assessment that might prompt
consideration of an alternate diagnosis (Level C based on assessment of benefit relative to harm, feasibility,
and cost relative to benefit).
2f In situations where there is no behavioral evidence of consciousness on clinical examination but functional
neuroimaging or electrophysiologic testing suggests the possibility of preserved conscious awareness,
frequent neurobehavioral reevaluations may be conducted to identify emerging signs of conscious awareness
(Level C based on feasibility) and decisions to reduce the intensity of rehabilitation treatment may be delayed
for those individuals receiving active rehabilitation management (Level C based on variation in patient
preferences and cost relative to net benefit), with the length of time over which these are done determined by
an agreement between the treating clinician and the health care proxy given the lack of evidence to provide
guidance.
Abbreviation: ACRM, American Congress of Rehabilitation Medicine.
a Level A is the strongest recommendation level and is denoted by use of the helping verb must. These recommendations are rare. Level B corresponds
to the helping verb should. Such recommendations are more common, as the requirements are less stringent but are still associated with confidence in
the rationale and a favorable benefiterisk profile. Level C corresponds to the helping verb may. These recommendations represent the lowest allowable
recommendation level that the American Academy of Neurology considers useful within the scope of clinical practice and can accommodate the highest
degree of practice variation.
1701such as individualized quantitative behavioral assessment have
been useful in distinguishing specific purposeful responses from
generalized, nonpurposeful, or reflexive responses.18 On the basis
of these findings, diagnostic accuracy may be enhanced by using
standardized neurobehavioral assessment measures over qualita-
tive bedside examination alone. If standardized assessments are
used, those with the highest quality of evidence should be
employed. A systematic review performed by ACRM recom-
mended the Coma Recovery ScaleeRevised (CRS-R),16 Wessex
Head Injury Matrix,19 Sensory Modality Assessment and
Rehabilitation Technique,20 Western NeuroSensory Stimulation
Protocol,21 Disorders of Consciousness Scale,22 and Sensory
Stimulation Assessment Measure23 for use in clinical practice.17
Recommendation 2b rationale
While there is insufficient high-quality evidence to recommend
the use of serial evaluations to improve diagnostic sensitivity and
specificity, because of the inconsistency and variability of
behavioral responses that is characteristic of individuals with
prolonged DoC, reliance on a single examination may contribute
to greater risk of misdiagnosis. Multiple behavioral evaluationswww.archives-pmr.orgover time may improve diagnostic reliability and accuracy as
compared with a single evaluation. Serial evaluations conducted
by trained clinicians using a standardized, validated neuro-
behavioral assessment instrument have the potential to improve
the reliability/validity of diagnosis. There are insufficient data to
recommend a minimum duration of time for an assessment session
or how often serial examinations should be performed. The fre-
quency of serial standardized neurobehavioral examinations
should be based on clinical judgment with consideration given to
reported changes in arousal and responsiveness, the removal or
cessation of diagnostic confounders, and the length of time since
the last assessment.
Recommendation 2c/2d rationale
Patients with prolonged DoC may exhibit inconsistent or reduced
behavioral responsiveness because of fluctuations in the level of
arousal, systemic medical problems, secondary neurologic com-
plications, and other adverse events (e.g., medication side effects).
Level of consciousness cannot be assessed accurately during
periods of low arousal. In patients who demonstrate fluctuations in
wakefulness, efforts should be made to increase arousal level
Table 2 Recommendation statements for prognosis for adults with a prolonged disorder of consciousness (DoC)
Recommendation Number Recommendation Statement and Level
3 When discussing prognosis with caregivers of patients with a DoC during the first 28 days postinjury,a clinicians
must avoid statements that suggest these patients have a universally poor prognosis (Level A).
4 Clinicians caring for patients with prolonged DoC should perform serial standardized behavioral evaluations to
identify trends in the trajectory of recovery that are important for establishing prognosis (Level B).
5 Posttraumatic VS/UWS: Clinicians should perform the DRS at 2e3 months postinjury (Level B) and may assess for
the presence of P300 at 2e3 months postinjury (Level C based on feasibility) or assess EEG reactivity at 2e3
months postinjury (Level C based on feasibility) to assist in prognostication regarding 12-month recovery of
consciousness for patients in traumatic VS/UWS. Clinicians should perform MRI 6e8 weeks postinjury to
assess for corpus callosal lesions, dorsolateral upper brainstem injury, or corona radiata injury in order to
assist in prognostication regarding remaining in PVS at 12 months for patients in traumatic VS/UWS (Level B).
Clinicians should perform a SPECT scan 1e2 months postinjury to assist in prognostication regarding 12-
month recovery of consciousness and degree of disability/recovery for patients in traumatic VS/UWS (Level B).
Clinicians may assess for the presence of higher level activation of the auditory association cortex using BOLD
fMRI in response to a familiar voice speaking the patient’s name to assist in prognostication regarding
12-month (postscan) recovery of consciousness for patients in traumatic VS/ UWS 1e60 months postinjury
(Level C based on feasibility, cost).
6 Nontraumatic, postanoxic VS/UWS: Clinicians should perform the CRS-R (Level B) and may assess SEPs (Level C
based on feasibility) to assist in prognostication regarding recovery of consciousness at 24 months for
patients in nontraumatic postanoxic VS/UWS.
7 Given the frequency of recovery of consciousness after 3 months in patients in nontraumatic VS/UWS, and after
12 months in patients with traumatic VS/UWS (including some cases emerging from MCS), use of the term
permanent VS should be discontinued. After these time points, the term chronic VS (UWS) should be applied,
accompanied by the duration of the VS/UWS (Level B).
Prognostic counseling recommendations
8 Clinicians should counsel families that MCS diagnosed within 5 months of injury and traumatic etiology are
associated with more favorable outcomes and VS/UWS and nontraumatic DoC etiology are associated with
poorer outcomes, but individual outcomes vary and prognosis is not universally poor (Level B based on
importance of outcomes).
9 In patients with a prolonged DoC, once a prognosis has been established that indicates a likelihood of severe long-
term disability, clinicians must counsel family members to seek assistance in establishing goals of care and
completing state-specific forms regardingmedical decision-making (e.g., MOLST forms), if not already available,
applying for disability benefits, and starting estate, caregiver, and long-term care planning (Level A).
10 When patients enter the chronic phase of VS/UWS (i.e., 3 months after non-TBI and 12 months after TBI),
prognostic counseling should be provided that emphasizes the likelihood of permanent severe disability and
the need for long-term assistive care (Level B).
Abbreviations: BOLD, blood oxygen leveledependent; CRS-R, Coma Recovery ScaleeRevised; DRS, Disability Rating Scale; MCS, minimally conscious
state; MOLST, medical orders for life-sustaining treatment; PVS, persistent vegetative state; SEP, somatosensory evoked potential; TBI, traumatic brain
injury; UWS, unresponsive wakefulness syndrome; VS, vegetative state.
a This is the one recommendation in this guideline pertaining to individuals in a DoC for less than 28 days. While patients with an acute DoC are not
the primary population covered by this guideline, the results of the systematic review and review of related evidence showing the potential for long-
term recovery in individuals with DoC lasting longer than 28 days also apply when counseling the families of patients who are <28 days from injury.
1702 J.T. Giacino et alusing protocols designed for this purpose (e.g., the CRS-R Arousal
Facilitation Protocol) before assessing the level of consciousness.
Identifying and treating conditions that impair neurologic
functioning may also improve arousal and level of consciousness.
Recommendation 2e/2f rationale
Our systematic review identified that some electrophysiologic
procedures (EMG thresholds for detecting response to motor
commands, EEG reactivity, laser-evoked potential responses, and
the Perturbational Complexity Index) possibly have value for
distinguishing MCS from VS/UWS, generally to an only mildly
important degree. There is insufficient evidence to support or
refute the routine clinical use of functional neuroimaging or
routine EEG or evoked response studies as clinically useful
adjuncts to behavioral evaluations to detect conscious awarenessin patients diagnosed with VS/UWS. In addition, functional
imaging is not widely available and may not be clinically feasible
in large numbers of patients. However, 2 reviewed studies iden-
tified fMRI changes in response to a word-counting task and an
incorrect-minus-correct activation protocol in patients diagnosed
with VS/UWS by the CRS-R (38%, 95% confidence interval [CI]
14%e69%, and 38%, 95% CI 23%e56%, respectively).24,25
Research studying DoC populations overlapping with those in
this guideline (i.e., cohorts including patients with a DoC for
longer than 28 days but not confined exclusively to patients with
prolonged DoC) suggests that some individuals without signs of
awareness on behavior-based evaluations may have positive
findings using other modalities, such as functional MRI, PET
scans, or electrophysiologic studies. In 1 study26 of patients with
VS/ UWS based on standardized neurobehavioral assessment,www.archives-pmr.org
Table 3 Recommendation statements for care and treatment for adults with a prolonged disorder of consciousness (DoC)
Recommendation Number Recommendation Statement and Level
11 Clinicians must identify patient and family preferences early and throughout provision of care to help guide the
decision-making process for persons with prolonged DoC (Level A).
12 Clinicians should be vigilant to the medical complications that commonly occur during the first few months after
injury among patients with DoC and, thus, should utilize a systematic assessment approach to facilitate
prevention, early identification, and treatment (Level B).
13 Clinicians should assess individuals with a DoC for evidence of pain or suffering and should treat when there is
reasonable cause to suspect that the patient is experiencing pain (Level B), regardless of level of
consciousness. Clinicians should counsel families that there is uncertainty regarding the degree of pain and
suffering that may be experienced by patients with a DoC (Level B).
14 Clinicians caring for patients with traumatic VS/UWS or MCS who are between 4 and 16 weeks postinjury should
prescribe amantadine 100e200 mg twice daily to hasten functional recovery and reduce degree of disability in
the early stages of recovery after determining there are no medical contraindications or other case-specific
risks for use (Level B).
15 Clinicians should counsel families about the limitations of existing evidence concerning treatment effectiveness
and the potential risks and harms associated with interventions that lack evidentiary support (Level B). When
discussing nonvalidated treatments, clinicians should provide evidence-based information regarding the
projected benefits and risks of a particular treatment and the level of uncertainty associated with the proposed
intervention, keeping in mind that families and caregivers are often in distress and vulnerable (Level B).
Clinicians should counsel families that, inmany cases, it is impossible to discern whether improvements observed
early in the course of recovery were caused by a specific intervention or spontaneous recovery (Level B).
Abbreviations: MCS, minimally conscious state; UWS, unresponsive wakefulness syndrome; VS, vegetative state.
1703functional neuroimaging studies (18F-fluorodeoxyglucose [FDG]
PET, fMRI) performed at various times postinjury demonstrated
evidence of brain activity compatible with at least minimal
conscious awareness in approximately 32% of patients scanned
using 18F-FDG PET or mental imagery fMRI or both (13/41; 95%
CI 20%e47%), with 18F-FDG PET showing results consistent
with MCS in 33% of patients diagnosed with VS/UWS by the
CRS-R (12/36, 95% CI 20%e50%) and mental imagery fMRI
showing results consistent with MCS in 11% (3/28, 95% CI 4%e
27%). When using high-density EEG recordings assessing a
combination of low-frequency power, EEG complexity, and in-
formation exchange in a population overlapping with that in this
guideline, 25 of 75 recordings in patients in VS/UWS (33%, 95%
CI 24%e45%) were classified as suggestive of MCS, with a
greater recovery of consciousness in those categorized as MCS
than VS/UWS on the EEG (11/50 VS vs 11/23 MCS, with 2 lost to
follow-up; risk difference 26%, 95% CI 3%e47%).27
Although multimodal evaluations show promise in increasing
sensitivity for detection of conscious awareness, these studies
return negative findings in the majority of patients diagnosed withTable 4 Recommendation statements for care for children with a prol
Recommendation Number Recommendation Statement and Level
16 Clinicians should treat confounding conditi
reliable standardized behavioral assessme
serial assessments to improve diagnostic
17 Clinicians should counsel families that the
well-defined and that there are no curre
population (Level B).
18 Clinicians should counsel families that the
(Level B).
www.archives-pmr.orgVS/UWS on behavioral assessment, and the exact link between
these findings and consciousness remains unclear. Widespread use
of multimodal imaging is unlikely to change the diagnosis in most
patients diagnosed with VS/UWS. At the same time, injury
sequelae (such as severe hypertonus) may confound behavioral
assessment and compromise diagnostic accuracy. In addition,
diagnostic findings may remain ambiguous despite serial assess-
ment due to the inconsistency or subtlety of the behavioral
evidence. The largest functional neuroimaging study conducted to
date in patients with DoC reported that ambiguous or erroneous
findings clouded clinical diagnosis in 33 of 126 (27%) cases.26
Recommendation 3 rationale
In patients with severe traumatic brain injury (TBI), many of
whom have a DoC, one study found that hospital mortality was
32%, with 70% of those deaths associated with the withdrawal of
life-sustaining therapy.4 Withdrawal of lifesustaining therapy was
more closely associated with the facility where care was provided
than with baseline characteristics, including age, sex, pupillaryonged disorder of consciousness (DoC)
ons, increase arousal prior to diagnostic assessments, use valid and
nts (particularly those targeting pediatric populations), and conduct
accuracy in children with prolonged DoC (Level B).
natural history and prognosis of children with prolonged DoC is not
nt evaluations established to improve prognostic accuracy in this
re are no established therapies for children with a prolonged DoC
1704 J.T. Giacino et alreactivity, and Glasgow Coma Scale motor score.4 While with-
drawal of life-sustaining therapy was high, this systematic review
identified that individuals with a DoC lasting longer than 1 month
postinjury may still attain functionally significant recovery after 1
year postinjury. Additional research shows that patients with
prolonged DoC can achieve at least some degree of functional
independence during long-term follow-up. For example, one study
found that approximately 20% of patients with a traumatic VS/
UWS DoC admitted to inpatient rehabilitation were judged to be
functionally independent and capable of returning to employment
at 1, 2, or 5 years.28 Another longitudinal study including patients
with traumatic and nontraumatic DoC reported that almost half of
the sample recovered to at least daytime independence at home
and 22% returned to school or work.29 While these studies may
not be fully generalizable, they suggest the potential for recovery
in this population, which has implications for prognostic
discussions.Recommendation 4 rationale
The natural history of DoC is not well-defined, particularly for
populations with nontraumatic brain injury, and diagnosis and
prognosis can be challenging. Individuals with DoC can fluctuate
between different diagnostic categories such as VS and MCS.
Fluctuation is particularly common early in the course of recov-
ery,30 and one study suggests a 30% probability of observing be-
haviors suggestive of MCS in patients diagnosed with VS/UWS
when assessments are conducted in the morning.7 Patients with VS
may also emerge to MCS over time. MCS is probably associated
with a better prognosis than VS. Serial examinations, already
suggested to improve diagnostic accuracy, may also aid prognosis
in view of the relationship between diagnosis and prognosis.Recommendation 5 rationale
In patients diagnosed with prolonged traumatic VS/UWS,
Disability Rating Scale (DRS) scores <26 at 2e3 months post-
injury, a detectable P300 at 2e3 months postinjury, a reactive
EEG at 2e3 months postinjury, and higher-level activation of the
auditory association cortex using blood oxygen leveledependent
fMRI in response to a familiar voice speaking the patient’s name
probably have prognostic utility, suggesting an increased chance
of recovering consciousness within 12 months. A normal SPECT
scan at 1e2 months postinjury, lower DRS scores in general 2e3
months postinjury, and a detectable P300 2e3 months postinjury
after controlling for DRS and EEG reactivity are possibly
associated with either an increased likelihood of recovery of
consciousness or a more favorable outcome, while MRI performed
6e8 weeks postinjury showing corpus callosal lesions, dorsolat-
eral upper brainstem injury, or corona radiata injury are possibly
associated with a worse prognosis at 12 months.Recommendation 6 rationale
In patients diagnosed with nontraumatic postanoxic VS/ UWS, it
is highly probable that CRS-R scores of 6 obtained more than 1
month after onset and the presence of somatosensory evoked
potentials from bilateral median nerve stimulation each have
prognostic utility as independent predictors of recovery, suggest-
ing an increased likelihood of recovery of responsiveness by 24
months postinjury.Recommendation 7 rationale
The 1994 AAN Multi-Society Task Force defined VS as per-
manent 3 months after a nontraumatic injury leading to VS and
12 months following a traumatic injury, acknowledging that
unexpected recoveries will occur after these times but that these
cases will be rare and typically associated with severe
disability.31 A reanalysis of the Task Force data concluded that
the estimated rates of late recovery for traumatic and non-
traumatic VS were unreliable due to inconsistent follow-up (only
27 cases were available with follow-up after 12 months), unre-
liable reporting (in some cases, follow-up was obtained through
“personal communications”), and questionable diagnostic accu-
racy.32 Relying only on the portion of the Task Force dataset that
was extracted from the Traumatic Coma Data Bank33 (which
appropriately defined VS and reported findings on 25 cases
followed after 12 months), 6 patients (14%) recovered con-
sciousness between 1 and 3 years postinjury. This recovery rate
is substantially higher than the 1.6% reported in the Task Force
Report and raised questions about the appropriateness of the term
permanent VS.
In the current systematic review, no study evaluated the
prognosis of patients with traumatic VS/UWS after 12 months of
injury. One Class II study mixing patients with traumatic and
nontraumatic VS/UWS found that none of these patients in VS/
UWS 12 months after onset improved when assessed at 2, 3, 4,
and 5 years postinjury (1 lost to follow-up, 9 died, and 2 remained
in VS/UWS), but due to the small sample size, CIs for the pos-
sibility of improving were wide (0%, 95% CI 0%e24%).34
Recent studies suggest that some patients with prolonged
nontraumatic VS/UWS may experience ongoing recovery after 3
months. Meta-analyses performed in this systematic review
found it is possible that 17% (95% CI 5%e30%) will recover
consciousness (emerge from VS/UWS) at 6 months. After 6
months, it is possible that an estimated 7.5% (95% CI 0%e24%)
may recover consciousness. In one study of prolonged anoxic
vegetative state included in the systematic review, of the 9 of 43
recovering responsiveness, 2 recovered between 3 and 6 months,
3 recovered at 6e12 months, and 4 recovered at 12e24 months.
Of the 2 individuals emerging from MCS, 1 patient recovered
consciousness at 16 months and emerged from MCS at 18
months and the other recovered consciousness at 22 months and
emerged from MCS at 25 months; both remained severely
disabled. Of 41 patients who remained in VS/UWS at 6 months,
7 additional patients recovered consciousness before 24 months
(17%, 95% CI 9%e31%).35 The natural history of nontraumatic
VS/UWS is likely tied to the underlying etiology, with non-
traumatic VS/ UWS related to a specific insult (e.g., anoxic
injury, ischemia) different from that relating to ongoing
neurodegeneration.
Additional evidence suggests that late transition to MCS from
VS/UWS may occur in as many as 20% of patients who meet
permanence criteria. One study followed 50 patients who
remained unconscious for a mean of 11.1 (4.8) months after
traumatic or nontraumatic brain injury and reported that 10
patients (7 traumatic, 3 nontraumatic) recovered consciousness
between 14 and 28 months postonset.36 A second study followed
108 patients with TBI across a 5-year interval, all of whom failed
to recover command-following during the course of inpatient
rehabilitation. Among the 17 patients who were still unable to
follow commands at 12 months postonset, 8 (47.0%) regained this
ability between 1 and 5 years postinjury.28www.archives-pmr.org
1705Although the majority of patients who remain in VS/UWS
across the first 3 (after nontraumatic) and 12 months (after trau-
matic) postinjury will remain in this condition permanently, a
substantial minority will recover consciousness beyond this time
frame. While most of these patients will be left with severe
disability, functional outcome ratings indicate that some will
regain the ability to communicate reliably, perform self-care
activities, and interact socially.37
In view of these findings, continued use of the term perma-
nent VS is not justified. Use of this term implies irreversibility,
which is not supported by the current research and has impli-
cations for family counseling, decision-making, and the ethics of
the field. The guideline panel suggests that the term permanent
VS be replaced by the term chronic VS to indicate the stability of
the condition (in keeping with other diseases that have a chronic
phase). This should be accompanied by a description of the
current duration of the VS/UWS, as evidence supports a
decreasing likelihood of recovery with longer duration of unre-
sponsiveness. Because most patients with late recovery of con-
sciousness will remain fully or partially dependent upon others
for activities of daily living, prognostic counseling should
emphasize the need for long-term care and specify the type of
supportive care required.
Recommendation 8 rationale
Systematic review evidence showed that in patients with pro-
longed DoC, those diagnosed with MCS within the first 5 months
of injury have a more favorable long-term prognosis for functional
recovery than those diagnosed with VS/UWS. Long-term prog-
nosis is also more favorable in patients in MCS who have
sustained traumatic vs nontraumatic brain injury.38 The evidence
reviewed does not clearly support or refute age and time post-
injury as prognostic features.
As described in the rationale for recommendation 3 above,
evidence from the systematic review identified that individuals
with a DoC at 1 month postinjury may still attain functionally
significant recovery after 1 year postinjury, with additional lon-
gitudinal studies showing that approximately 20% of patients
recover to the level where they could return to work or school.28,29
Recommendation 9 rationale
Patients with prolonged DoC may have a prolonged recovery over
months to years, and many will remain severely disabled.
Employment and personal finances in the short term and the long
term will be significantly affected, and these effects will have
implications for family members. Patients and families benefit
from planning in advance for an expected prolonged recovery.
Recommendation 10 rationale
See rationale for recommendation 7.
Recommendation 11 rationale
Preexpressed wishes of patients with prolonged DoC and values of
families of persons with prolonged DoC can be highly variable.
Values may also change over the course of illness. Personal values
should be identified early and need to be reassessed over time
when making decisions regarding care for individuals with pro-
longed DoC.www.archives-pmr.orgRecommendation 12 rationale
Complication rates are high in patients with prolonged DoC and
negatively affect morbidity and mortality.5,39,40,e1 It is important
that clinicians remain vigilant to medical complications in the
short term to facilitate their early identification and to help
optimize long-term outcomes. The most common complications in
patients with prolonged DoC include agitation/aggression,
hypertonia, sleep disturbance, and urinary tract infections.37
Other, more severe complications, such as hydrocephalus, pneu-
monia, and paroxysmal sympathetic hyperactivity, can disrupt
rehabilitation efforts, as they often require rehospitalization.37
Strategies for early detection and rapid management of compli-
cations include daily physician rounds, 24-hour specialty
physician coverage, on-site availability of diagnostic resources,
and timely access to specialty consultations.37
Recommendation 13 rationale
The potential to experience pain and suffering is an issue
frequently raised with respect to treatment, ethical, and legal
questions in individuals with DoC. Some studies using functional
imaging indicate that brain activation in networks supporting pain
perception is lower in patients diagnosed with VS compared with
those in MCS and conscious controls, suggesting that patients in
VS lack capacity for full pain awareness.e2,e3 Other studies sug-
gest that the relationship between level of consciousness and pain
perception is unclear.e4,e5 Accurate assessment of pain and
suffering in individuals with DoC is limited by challenges in
accurately diagnosing pain due to the level of consciousness and
conflicting evidence regarding the potential of patients in VS or
MCS to experience pain and suffering. Clinicians should be
cautious in making definitive conclusions about pain and suffering
in individuals with DoC.
Recommendation 14 rationale
Amantadine (100e200 mg twice daily), when administered over a
period of 4 weeks in patients between 16 and 65 years old with
traumatic DoC who are between 4 and 16 weeks of injury, prob-
ably hastens functional recovery in the early stages. Faster
recovery reduces the burden of disability, lessens health care costs,
and minimizes psychosocial stressors in patients and caregivers.
Recommendation 15 rationale
Most therapies proposed for treating patients with DoC (e.g.,
hyperbaric oxygen, nutraceuticals, stem cell therapies, primrose
oil) have insufficient evidence to support or refute their use, and
many have associated risks. Families may pursue these treatments
in the absence of evidence because they are desperate for ways to
help their loved one and interventions supported by high-quality
evidence are sparse. Counseling families about treatment effec-
tiveness is complicated by the difficulties inherent in determining
whether improvements observed early in the course of recovery
are related to interventions or due to spontaneous recovery.
Recommendation 16 rationale
No evidence was identified regarding the diagnosis of children
with prolonged DoC. In the absence of pediatric-specific evidence,
it is reasonable to apply the diagnostic recommendations for adult
1706 J.T. Giacino et alpopulations that address the treatment of confounding conditions
to improve diagnosis, the importance of increasing arousal prior to
diagnostic assessments, using valid and reliable standardized
behavioral assessments, and conducting serial assessments to
children with DoC.Recommendation 17 rationale
The natural history of DoC in children is not well-defined. In
children with prolonged DoC, traumatic etiology is possibly
associated with a better chance of recovery, as is the absence of
posttraumatic autonomic dysfunction. Posttraumatic hyperthermia
may be associated with a worse outcome. No other evidence
was identified.
Recommendation 18 rationale
No identified therapeutic studies enrolled pediatric populations.
The only therapeutic intervention shown to have efficacy in adults
(16e65 years) is amantadine. A retrospective case-controlled
study of amantadine use in patients with TBI reported that 9% of
children taking this treatment had side effects, but methodologic
concerns limit therapeutic conclusions from this study.Author contributions
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